Clearside Biomedical's market cap is currently $21.15M. The company's EPS TTM is $-1.5; its P/E ratio is ―; Clearside Biomedical is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.
